Free tool
Healthcare stocks
We cover 542 companies in the Healthcare sector. The median market value in the group is $4.20B. Across the group, the median move over the past trading day is −0.06%. 63% of the 528 with a 200-day average trade above it. Price change over the past year runs from −58.4% to +159.4% across the middle 80 percent of the group, with a median of +11.3%. Across the group, 3 companies currently carry a tier A volume signal.
Other lists in this group
Table
542 of 2,203 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| CTSO | Cytosorbents Corporation | $22.62M | Micro cap | −61.29% | Nov 12, 2026 |
| LGVN | Longeveron Inc. | $21.68M | Micro cap | −14.44% | Nov 4, 2026 |
| LFWD | Lifeward Ltd. | $20.93M | Micro cap | +0.03% | Nov 12, 2026 |
| TPST | Tempest Therapeutics, Inc. | $17.86M | Micro cap | −89.96% | Nov 5, 2026 |
| BIVI | BioVie Inc. | $17.83M | Micro cap | +30.25% | Nov 9, 2026 |
| AELIS.PA | Aelis Farma SA | $16.34M | Micro cap | −19.22% | Sep 15, 2026 |
| LSTA | Lisata Therapeutics, Inc. | $15.68M | Micro cap | −30.40% | Nov 5, 2026 |
| DARE | Daré Bioscience, Inc. | $14.54M | Micro cap | −62.84% | Nov 12, 2026 |
| BNGO | Bionano Genomics, Inc. | $14.25M | Micro cap | −68.97% | Nov 12, 2026 |
| AVCN.TO | Avicanna Inc. | $12.59M | Micro cap | −52.73% | Nov 13, 2026 |
| PDSB | PDS Biotechnology Corporation | $12.49M | Micro cap | −82.56% | Nov 12, 2026 |
| IRIX | IRIDEX Corporation | $12.31M | Micro cap | −45.58% | Nov 17, 2026 |
| BLRX | BioLineRx Ltd. | $11.79M | Micro cap | −26.63% | Aug 31, 2026 |
| VTGN | Vistagen Therapeutics, Inc. | $11.54M | Micro cap | −91.82% | Nov 12, 2026 |
| VIVE.ST | Vivesto AB | $10.39M | Micro cap | −57.13% | Nov 12, 2026 |
| AMS | American Shared Hospital Services | $10.04M | Micro cap | −38.62% | Nov 12, 2026 |
| LNAI | Lunai Bioworks Inc. | $9.97M | Micro cap | −89.34% | Sep 28, 2026 |
| LUCY | Lucyd, Inc | $9.73M | Micro cap | −42.05% | Nov 12, 2026 |
| SKYE | Skye Bioscience, Inc. | $8.92M | Micro cap | −41.62% | Nov 9, 2026 |
| CODX | Co-Diagnostics, Inc. | $8.73M | Micro cap | −87.22% | Nov 16, 2026 |
| EVGN | Evogene Ltd. | $8.58M | Micro cap | −58.55% | Nov 19, 2026 |
| ICCM | IceCure Medical Ltd | $7.85M | Micro cap | +132.49% | Nov 18, 2026 |
| INM | InMed Pharmaceuticals Inc. | $7.64M | Micro cap | −36.44% | Sep 23, 2026 |
| AVNT.TO | Avant Brands Inc. | $6.51M | Micro cap | −28.57% | Oct 15, 2026 |
| ACXP | Acurx Pharmaceuticals, Inc. | $6.15M | Micro cap | −70.64% | Nov 11, 2026 |
| CLGN | CollPlant Biotechnologies Ltd. | $5.81M | Micro cap | −89.43% | Aug 27, 2026 |
| CDIO | Cardio Diagnostics Holdings, Inc. | $5.71M | Micro cap | −48.46% | Nov 6, 2026 |
| CSCI.TO | COSCIENS Biopharma Inc. | $5.24M | Micro cap | +60.79% | Nov 10, 2026 |
| BCAB | BioAtla, Inc. | $5.20M | Micro cap | −86.04% | Nov 12, 2026 |
| VVOS | Vivos Therapeutics, Inc. | $5.11M | Micro cap | −94.48% | Nov 16, 2026 |
| XAIR | Beyond Air, Inc. | $4.89M | Micro cap | +117.98% | Nov 10, 2026 |
| VNRX | VolitionRx Limited | $4.89M | Micro cap | −97.47% | Nov 12, 2026 |
| JAGX | Jaguar Health, Inc. | $4.78M | Micro cap | −98.52% | Nov 12, 2026 |
| XRTX | XORTX Therapeutics Inc. | $4.03M | Micro cap | −43.99% | Nov 12, 2026 |
| CRIS | Curis, Inc. | $3.86M | Micro cap | −5.52% | Nov 5, 2026 |
| REVB | Revelation Biosciences, Inc. | $3.80M | Micro cap | −91.25% | Nov 5, 2026 |
| TNON | Tenon Medical, Inc. | $3.48M | Micro cap | +297.71% | Nov 12, 2026 |
| NXGL | NEXGEL, Inc. | $3.47M | Micro cap | −84.79% | Nov 10, 2026 |
| NUWE | Nuwellis, Inc. | $3.21M | Micro cap | −80.39% | Nov 11, 2026 |
| EXPRS2.ST | ExpreS2ion Biotech Holding AB (publ) | $3.19M | Micro cap | −93.99% | Nov 12, 2026 |
| AEMD | Aethlon Medical, Inc. | $1.62M | Micro cap | −85.66% | Nov 11, 2026 |
| APLI.TO | Appili Therapeutics Inc. | $1.44M | Micro cap | −25.00% | Nov 12, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.